Universidad de Buenos Aires-CONICET, Instituto de Investigaciones Biomédicas (INBIOMED), Buenos Aires, Argentina.
Universidad de Buenos Aires-CONICET, Instituto de Investigaciones Biomédicas (INBIOMED), Buenos Aires, Argentina; Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Buenos Aires, Argentina.
STAR Protoc. 2024 Sep 20;5(3):103210. doi: 10.1016/j.xpro.2024.103210. Epub 2024 Jul 13.
The understanding of anti-tumor drug effects requires specific experimental settings which model clinical scenarios. We describe a protocol for 10-day treatment of lowly aggressive tumor cell lines with antineoplastic agents at concentrations which do not affect cell growth. We describe steps for seeding cells and treating cells with anti-tumor drugs. We then detail steps for cell sensitivity, cell proliferation, and mRNA and protein expression assays. We also detail assays to determine modifications in compound efflux. For complete details on the use and execution of this protocol, please refer to Rios Medrano et al..
抗肿瘤药物效果的理解需要特定的实验设置来模拟临床情况。我们描述了一种方案,即用不会影响细胞生长的浓度,用抗肿瘤药物处理低度侵袭性肿瘤细胞系 10 天。我们描述了接种细胞和用抗肿瘤药物处理细胞的步骤。然后详细介绍了细胞敏感性、细胞增殖以及 mRNA 和蛋白质表达测定的步骤。我们还详细介绍了用于确定化合物外排变化的测定方法。有关该方案使用和执行的完整详细信息,请参阅 Rios Medrano 等人的研究。